American Journal of Neuroradiology, Vol 14, Issue 4 1014-1016, Copyright © 1993 by American Society of Neuroradiology
ARTICLES |
High-dose cytarabine neurotoxicity: MR findings during the acute phase
DJ Vaughn, JG Jarvik, D Hackney, S Peters and EA Stadtmauer
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.
The authors report an acute cerebral and cerebellar syndrome in a patient treated with high-dose cytarabine. Diffuse high-intensity lesions in the central white matter on T2-weighted MR completely reversed with resolution of the clinical syndrome. Although the autopsy revealed cerebellar injury, the cerebral cortex was grossly and microscopically normal, consistent with a reversible process.
This article has been cited by other articles:
 |
|
 |
|
  W.S. Bartynski Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1036 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski and J.F. Boardman Catheter Angiography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy Syndrome AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 447 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski and J.F. Boardman Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy Syndrome AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1320 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.S. Bartynski, J.F. Boardman, Z.R. Zeigler, R.K. Shadduck, and J. Lister Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2179 - 2190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Niyadurupola, C A M Burnett, and L E Allen Reversible posterior leucoencephalopathy syndrome: a cause of temporary cortical blindness Br. J. Ophthalmol., July 1, 2005; 89(7): 924 - 925. [Full Text] [PDF]
|
|
|
|
|
|
W. S. Bartynski, Z. R. Zeigler, R. K. Shadduck, and J. Lister Pretransplantation Conditioning Influence on the Occurrence of Cyclosporine or FK-506 Neurotoxicity in Allogeneic Bone Marrow Transplantation AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 261 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.D. Henderson, T. Rajah, A.J. Nicol, and S.J. Read Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm Neurology, January 28, 2003; 60(2): 326 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.K. Shin, J.W. Stern, A.J. Janss, J.V. Hunter, and G.T. Liu Reversible posterior leukoencephalopathy during the treatment of acute lymphoblastic leukemia Neurology, February 13, 2001; 56(3): 388 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R K Garg Posterior leukoencephalopathy syndrome Postgrad. Med. J., January 1, 2001; 77(903): 24 - 24. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. J. Cooney, W. G. Bradley, S. C. Symko, S. T. Patel, and P. K. Groncy Hypertensive Encephalopathy: Complication in Children Treated for Myeloproliferative Disorders-Report of Three Cases Radiology, March 1, 2000; 214(3): 711 - 716. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Vera, P. Rohrlich, J. L. Stievenart, M. Elmaleh, M. Duval, F. Bonnin, B. Bok, and E. Vilmer Contribution of Single-Photon Emission Computed Tomography in the Diagnosis and Follow-Up of CNS Toxicity of a Cytarabine-Containing Regimen in Pediatric Leukemia J. Clin. Oncol., September 1, 1999; 17(9): 2804 - 2804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hinchey, C. Chaves, B. Appignani, J. Breen, L. Pao, A. Wang, M. S. Pessin, C. Lamy, J.-L. Mas, and L. R. Caplan A Reversible Posterior Leukoencephalopathy Syndrome N. Engl. J. Med., February 22, 1996; 334(8): 494 - 500. [Abstract] [Full Text] [PDF]
|
|